BA
TMO icon

Boston Advisors’s Thermo Fisher Scientific TMO Stock Holding History

Boston Advisors’s Portfolio TMO Stock Details TMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		$3.94M Buy
13,531
+11,307
+508% +$3.24M 0.21% 131
2019
Q2 		$653K Hold
2,224
– – 0.03% 436
2019
Q1 		$609K Sell
2,224
-160
-7% -$39.8K 0.03% 436
2018
Q4 		$534K Sell
2,384
-24
-1% -$5.63K 0.03% 442
2018
Q3 		$588K Sell
2,408
-40
-2% -$9.2K 0.03% 461
2018
Q2 		$507K Sell
2,448
-26
-1% -$5.52K 0.01% 488
2018
Q1 		$511K Hold
2,474
– – 0.01% 492
2017
Q4 		$470K Buy
2,474
+269
+12% +$51.5K 0.01% 499
2017
Q3 		$417K Sell
2,205
-225
-9% -$40.7K 0.01% 516
2017
Q2 		$424K Sell
2,430
-460
-16% -$77.3K 0.01% 520
2017
Q1 		$444K Sell
2,890
-38,581
-93% -$5.9M 0.01% 494
2016
Q4 		$5.85M Sell
41,471
-8,788
-17% -$1.3M 0.14% 196
2016
Q3 		$7.99M Sell
50,259
-1,005
-2% -$155K 0.2% 146
2016
Q2 		$7.58M Sell
51,264
-23,487
-31% -$3.47M 0.19% 146
2016
Q1 		$10.6M Buy
74,751
+253
+0.3% +$33.9K 0.26% 114
2015
Q4 		$10.6M Buy
74,498
+70,898
+1,969% +$9.46M 0.25% 123
2015
Q3 		$440K Hold
3,600
– – 0.02% 564
2015
Q2 		$467K Hold
3,600
– – 0.02% 487
2015
Q1 		$484K Hold
3,600
– – 0.02% 470
2014
Q4 		$451K Hold
3,600
– – 0.02% 361
2014
Q3 		$438K Hold
3,600
– – 0.02% 364
2014
Q2 		$425K Sell
3,600
-902
-20% -$106K 0.02% 380
2014
Q1 		$541K Buy
4,502
+202
+5% +$24K 0.02% 331
2013
Q4 		$479K Sell
4,300
-3,554
-45% -$353K 0.02% 346
2013
Q3 		$724K Sell
7,854
-96
-1% -$8.68K 0.04% 288
2013
Q2 		$673K Buy
+7,950
New +$662K 0.03% 291

Other funds holding TMO

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Boston Advisors's TMO Position: Q3 2019 in Review

Boston Advisors increased its Thermo Fisher Scientific (TMO) stake by 508% in Q3 2019, buying an estimated $3.24M and bringing the position to 13,531 shares worth $3.94M. The position accounts for 0.21% of the portfolio, ranked #131.

Boston Advisors first reported a position in TMO in Q2 2013 and has held it in 26 quarters since. The position peaked at $10.6M in Q1 2016. 1,543 funds tracked by Wall St. Rank hold TMO as of Q3 2019.

  • Boston Advisors held 13,531 shares of Thermo Fisher Scientific worth $3.94M as of Q3 2019.
  • Boston Advisors bought 11,307 Thermo Fisher Scientific shares in Q3 2019, an estimated $3.24M.
  • Thermo Fisher Scientific made up 0.21% of Boston Advisors's portfolio in Q3 2019, its #131 holding.
  • Boston Advisors first reported a position in Thermo Fisher Scientific in Q2 2013 and has held it in 26 quarters since.
  • Boston Advisors's Thermo Fisher Scientific position peaked at $10.6M in Q1 2016.
  • 1,543 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q3 2019.

Based on Boston Advisors's 13F filing for Q3 2019, filed 5 Nov 2019.